A Study to Evaluate the Effects of a Single and Multiple Oral Doses of GLPG3121 in Adult, Healthy, Male Subjects
Clinical trial NCT03899909 · COMPLETED
Trial details
- NCT number
- NCT03899909
- Sponsor
- Lakefront Biotherapeutics NV
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-29
- Primary completion
- 2019-06-03
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.